Original Article
You have full text access to this OnlineOpen article
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
Article first published online: 2 NOV 2009
DOI: 10.1002/ibd.21161
Copyright © 2009 Crohn's & Colitis Foundation of America, Inc.
Additional Information
How to Cite
Lukas, M., Drastich, P., Konecny, M., Gionchetti, P., Urban, O., Cantoni, F., Bortlik, M., Duricova, D. and Bulitta, M. (2010), Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis, 16: 1180–1186. doi: 10.1002/ibd.21161
Publication History
- Issue published online: 11 JUN 2010
- Article first published online: 2 NOV 2009
- Manuscript Accepted: 1 OCT 2009
- Manuscript Received: 29 SEP 2009
Funded by
- Supported by AM-Pharma BV, Bunnik, The Netherlands, who provided AP enzyme for the study
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , , , , , , , , Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis, Inflammatory Bowel Diseases, 2011, 17, 2Direct Link:

1536-4844/asset/IBD_left.gif?v=1&s=9aca2b5041534c51cac4bb66560294c77a457a07)
1536-4844/asset/IBD_right.gif?v=1&s=402e3e241083497ae622916e85e47f64138255a4)
